CELL(Delisted)
PhenomeXยทNASDAQ
--
--(--)
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About CELL
Phenomex Inc.
A life sciences tools company that developing biotherapeutics and other cell-based products
5858 Horton Street, Suite 320, Emeryville, California 94608
--
PhenomeX Inc., a Delaware corporation. PhenomeX enables scientists to fully harness the potential of each cell to advance the next era of functional cell biology and advance human health. They allow scientists to reveal the most complete insights into cell function and provide a comprehensive understanding of how each cell behaves. Their unique suite of proven high-throughput tools and services delivers unparalleled resolution and speed, accelerating insights that are key to advancing discoveries that can profoundly improve disease prevention and treatment. Their award-winning platform is used by researchers around the world, including researchers from the world's top 15 pharmaceutical companies, and about 85 percent of the leading comprehensive cancer centers in the United States.
Company Financials
EPS
CELL has released its 2023 Q2 earnings. EPS was reported at -0.33, versus the expected -0.32, missing expectations. The chart below visualizes how CELL has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
CELL has released its 2023 Q2 earnings report, with revenue of 14.06M, reflecting a YoY change of -26.57%, and net profit of -50.24M, showing a YoY change of -95.15%. The Sankey diagram below clearly presents CELL's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
No Data
You can ask Aime
No Data
